| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 31,979 | 28,229 | 21,476 | 29,092 | | Cost of Revenue | 20,653 | 19,433 | 14,610 | 19,556 | | | Gross Profit | 11,326 | 8,796 | 6,865 | 9,536 | | | Operating Expenses | | Research Development | 3,556 | 3,786 | 3,151 | 3,120 | | Selling General and Administrative | 3,496 | 2,558 | 4,453 | 3,076 | | Non Recurring | 927 |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,274 | 2,452 | (739) | 3,340 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,460 | 1,538 | 3,256 | (968) | | Earnings Before Interest And Taxes | 7,808 | 3,990 | 2,517 | 2,372 | | Interest Expense |
-
|
-
|
-
| 15 | | Income Before Tax | 7,808 | 3,990 | 2,517 | 2,357 | | Income Tax Expense | 162 | 367 | 269 | (17) | | Minority Interest | 101 | 16 |
-
| (86) | | | | Net Income From Continuing Ops | 8,519 | 3,497 | 2,100 | 1,812 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,519 | 3,497 | 2,100 | 1,812 | | Preferred Stock And Other Adjustments |
-
| 184 | (184) |
-
| | | Net Income Applicable To Common Shares | $8,519 | $3,681 | $1,916 | $1,812 |
|
0.51% Nasdaq 
Income Statement
